The post Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease appeared on BitcoinEthereumNews.com. Felix Pinkston Oct 23, 2025 19:48 Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment. Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition. Leveraging AI and Real-World Data The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD. Aiming for Transformative Clinical Insights Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide. Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts… The post Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease appeared on BitcoinEthereumNews.com. Felix Pinkston Oct 23, 2025 19:48 Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment. Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition. Leveraging AI and Real-World Data The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD. Aiming for Transformative Clinical Insights Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide. Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts…

Oracle and Baylor College Partner to Combat Alcohol-related Liver Disease



Felix Pinkston
Oct 23, 2025 19:48

Oracle Health and Baylor College of Medicine collaborate to enhance research on alcohol-related liver disease, leveraging AI and real-world data for improved diagnosis and treatment.

Oracle Health and Life Sciences has announced a strategic collaboration with Baylor College of Medicine to advance research into alcohol-related liver disease (ALD), a growing public health concern in the United States. This partnership aims to harness state-of-the-art technology and data analytics to improve clinical insights and outcomes for patients affected by this condition.

Leveraging AI and Real-World Data

The collaboration will utilize Oracle Health’s AI data platform, which includes over 120 million longitudinal anonymized patient records. Baylor College of Medicine plans to expand its real-world data cohort to encompass more than one million patients. This significant dataset aims to facilitate earlier identification of ALD, enhance understanding of its progression, and inform more effective prevention and treatment strategies.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of early identification in altering disease outcomes. She highlighted the potential of combining Oracle’s robust data capabilities with Baylor’s expertise in clinical research and patient care to transform the study and treatment of ALD.

Aiming for Transformative Clinical Insights

Baylor College of Medicine intends to employ Oracle’s comprehensive datasets and AI tools to identify patterns, risk factors, and predictive markers in ALD progression. The collaboration aims to empower clinicians with actionable insights that can enhance patient care and inform public health strategies to mitigate ALD’s impact nationwide.

Dr. Hashem El-Serag, Vice President for the Learning Health System Initiative at Baylor College of Medicine, expressed optimism about the partnership’s potential to accelerate discovery and improve clinical practice. He noted that building one of the largest ALD cohorts in the country would create a valuable research resource and advance early intervention efforts for at-risk patients.

Addressing a Growing Health Challenge

According to recent studies, alcohol-related liver disease is increasingly prevalent in the U.S., particularly among younger populations. The collaboration between Oracle Health and Baylor College of Medicine seeks to address this urgent health challenge by combining advanced health technology with leading academic research.

For more information, visit the official announcement on Oracle’s website.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-baylor-college-combat-alcohol-liver-disease

Market Opportunity
Omnity Network Logo
Omnity Network Price(OCT)
$0.02724
$0.02724$0.02724
-8.77%
USD
Omnity Network (OCT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment?

The post Is Doge Losing Steam As Traders Choose Pepeto For The Best Crypto Investment? appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 17:39 Is dogecoin really fading? As traders hunt the best crypto to buy now and weigh 2025 picks, Dogecoin (DOGE) still owns the meme coin spotlight, yet upside looks capped, today’s Dogecoin price prediction says as much. Attention is shifting to projects that blend culture with real on-chain tools. Buyers searching “best crypto to buy now” want shipped products, audits, and transparent tokenomics. That frames the true matchup: dogecoin vs. Pepeto. Enter Pepeto (PEPETO), an Ethereum-based memecoin with working rails: PepetoSwap, a zero-fee DEX, plus Pepeto Bridge for smooth cross-chain moves. By fusing story with tools people can use now, and speaking directly to crypto presale 2025 demand, Pepeto puts utility, clarity, and distribution in front. In a market where legacy meme coin leaders risk drifting on sentiment, Pepeto’s execution gives it a real seat in the “best crypto to buy now” debate. First, a quick look at why dogecoin may be losing altitude. Dogecoin Price Prediction: Is Doge Really Fading? Remember when dogecoin made crypto feel simple? In 2013, DOGE turned a meme into money and a loose forum into a movement. A decade on, the nonstop momentum has cooled; the backdrop is different, and the market is far more selective. With DOGE circling ~$0.268, the tape reads bearish-to-neutral for the next few weeks: hold the $0.26 shelf on daily closes and expect choppy range-trading toward $0.29–$0.30 where rallies keep stalling; lose $0.26 decisively and momentum often bleeds into $0.245 with risk of a deeper probe toward $0.22–$0.21; reclaim $0.30 on a clean daily close and the downside bias is likely neutralized, opening room for a squeeze into the low-$0.30s. Source: CoinMarketcap / TradingView Beyond the dogecoin price prediction, DOGE still centers on payments and lacks native smart contracts; ZK-proof verification is proposed,…
Share
BitcoinEthereumNews2025/09/18 00:14
Fed Decides On Interest Rates Today—Here’s What To Watch For

Fed Decides On Interest Rates Today—Here’s What To Watch For

The post Fed Decides On Interest Rates Today—Here’s What To Watch For appeared on BitcoinEthereumNews.com. Topline The Federal Reserve on Wednesday will conclude a two-day policymaking meeting and release a decision on whether to lower interest rates—following months of pressure and criticism from President Donald Trump—and potentially signal whether additional cuts are on the way. President Donald Trump has urged the central bank to “CUT INTEREST RATES, NOW, AND BIGGER” than they might plan to. Getty Images Key Facts The central bank is poised to cut interest rates by at least a quarter-point, down from the 4.25% to 4.5% range where they have been held since December to between 4% and 4.25%, as Wall Street has placed 100% odds of a rate cut, according to CME’s FedWatch, with higher odds (94%) on a quarter-point cut than a half-point (6%) reduction. Fed governors Christopher Waller and Michelle Bowman, both Trump appointees, voted in July for a quarter-point reduction to rates, and they may dissent again in favor of a large cut alongside Stephen Miran, Trump’s Council of Economic Advisers’ chair, who was sworn in at the meeting’s start on Tuesday. It’s unclear whether other policymakers, including Kansas City Fed President Jeffrey Schmid and St. Louis Fed President Alberto Musalem, will favor larger cuts or opt for no reduction. Fed Chair Jerome Powell said in his Jackson Hole, Wyoming, address last month the central bank would likely consider a looser monetary policy, noting the “shifting balance of risks” on the U.S. economy “may warrant adjusting our policy stance.” David Mericle, an economist for Goldman Sachs, wrote in a note the “key question” for the Fed’s meeting is whether policymakers signal “this is likely the first in a series of consecutive cuts” as the central bank is anticipated to “acknowledge the softening in the labor market,” though they may not “nod to an October cut.” Mericle said he…
Share
BitcoinEthereumNews2025/09/18 00:23
Coinbase Joins Ethereum Foundation to Back Open Intents Framework

Coinbase Joins Ethereum Foundation to Back Open Intents Framework

Coinbase Payments has joined the Open Intents Framework as a core contributor, working alongside Ethereum Foundation and other major players. The initiative aims to simplify complex multi-chain interactions through automated solver technology. The post Coinbase Joins Ethereum Foundation to Back Open Intents Framework appeared first on Coinspeaker.
Share
Coinspeaker2025/09/18 02:43